MoonLake Immunotherapeutics
MLTX
#5619
Rank
NZ$2.16 B
Marketcap
NZ$30.58
Share price
-2.71%
Change (1 day)
-62.40%
Change (1 year)

Market capitalization of MoonLake Immunotherapeutics (MLTX)

Market cap: NZ$2.16 Billion

As of January 2026 MoonLake Immunotherapeutics has a market cap of NZ$2.16 Billion. This makes MoonLake Immunotherapeutics the world's 5619th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of MoonLake Immunotherapeutics from 2022 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.16 B28.06%
2025NZ$1.69 B-72.68%
2024NZ$6.19 B8.17%
2023NZ$5.72 B787.96%
2022NZ$0.64 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of MoonLake Immunotherapeutics was reported to be:

NZ$2.01 Billion
by Nasdaq info icon info icon
NZ$2.22 Billion
by CompaniesMarketCap info icon info icon